Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice. - Wikidata - awgldk - TriplyDB

Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.

Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.

http://www.wikidata.org/entity/Q34020747

about

Aqueous outflow - A continuum from trabecular meshwork to episcleral veins Animal models of glucocorticoid-induced glaucoma A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma.Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and Matrix Hic-5 Regulates Actin Cytoskeletal Reorganization and Expression of Fibrogenic Markers and Myocilin in Trabecular Meshwork Cells Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management.Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone.Elevation of intraocular pressure in rodents using viral vectors targeting the trabecular meshwork.Physical Factors Affecting Outflow Facility Measurements in Mice.Dose- and time-dependent effects of actomyosin inhibition on live mouse outflow resistance and aqueous drainage tissues High osmotic pressure increases reactive oxygen species generation in rabbit corneal epithelial cells by endoplasmic reticulum.Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy.Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.Severe Corticosteroid-Induced Ocular Hypertension Requiring Bilateral Trabeculectomies in a Patient with Takayasu's Arteritis.VEGF as a Paracrine Regulator of Conventional Outflow Facility.Roles of exosomes in the normal and diseased eye.Model systems for the study of steroid-induced IOP elevation.Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.Mechanical analysis of rat trabecular meshwork.Rodent models of glaucoma and their applicability for drug discovery.Neuroinflammation in glaucoma: A new opportunity.Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes.A useful mouse model of glucocorticoid-induced ocular hypertension.Differential response and withdrawal profile of glucocorticoid-treated human trabecular meshwork cells.Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.Increased synthesis and deposition of extracellular matrix proteins leads to endoplasmic reticulum stress in the trabecular meshwork.Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway.Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration.Glucocorticoid receptor GRβ regulates glucocorticoid-induced ocular hypertension in mice.Trabodenoson, an Adenosine Mimetic With A1 Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice.The relationship between outflow resistance and trabecular meshwork stiffness in mice.Methods to Induce Chronic Ocular Hypertension: Reliable Rodent Models as a Platform for Cell Transplantation and Other Therapies.Glaucomatous cell derived matrices differentially modulate non-glaucomatous trabecular meshwork cellular behavior.Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.Absence of a secondary glucocorticoid response in C57BL/6J mice treated with topical dexamethasone.Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.

P2860

Q28078135-F3655041-1202-4B0B-94B6-C4D6FE7D53A3 Q28085360-3FD84781-F8CE-47D8-B07A-61927D8A5F45 Q28469378-6450B596-70DF-4BFC-92F9-15A1B73DE3C1 Q33561615-46467C78-D559-46F7-9858-6D0BFB6D5A6A Q35870345-EB5F3310-E6E8-431F-A477-276FA11E948D Q36008830-B4375E70-D1AC-4D14-8754-923D11C3ADEB Q36013578-03D6BE02-ACC0-4F83-87F9-C3173E51E2FE Q36174962-F3CEF467-04EC-40A1-ABC8-82EFA7FE7260 Q36236887-C84CBF79-8B9A-4EF6-90AD-62B49DB17132 Q36425029-6D005060-66AA-4CE3-8DA1-FB44A4450749 Q36588581-D228B71E-81C8-44C7-B93E-BC8094FF5427 Q36841271-B56D3E22-19C5-480F-9851-DAB6E67CC343 Q36880023-1B60A00C-135E-4234-8DF8-0D9FDFCB4A2C Q37059858-D20A4380-1476-48C4-B6AD-57E58386761B Q37434479-007031A3-34B3-449C-B7CF-C0EDDF60EE27 Q37731916-5F526B22-D5B7-4943-B592-3B015BAC0755 Q38688358-C7764CD8-A983-4057-B03C-28053703501A Q38906581-87E17696-6E87-4873-B639-DAD254265425 Q38963936-47D86CCE-4083-4764-BC9F-A3C903F02EC3 Q39035846-080D47D6-A95A-4047-A816-3B630EDB6E1F Q39079602-26B651B5-86B0-4943-A9B0-67781DDE62AC Q39153080-D9AA4066-1F6D-423C-8BB5-2AB46D7E8825 Q41036726-0104232D-4A0A-4061-8D6E-1A2DAEA431E8 Q42003113-D5544117-DF03-45A3-99C3-0E43839BA3D6 Q42502874-A98AAC62-8944-48B9-98F8-48EB8B5A0BE3 Q43991565-2AEDF095-4BAE-4356-A873-506EDF6AF202 Q44560624-6C6FF4AA-66B8-4892-A2A4-1EB589044547 Q45872509-D454B826-179A-4D4C-BA55-15E2C8AB0E59 Q47333845-04430C94-4195-40F9-8BA7-D34CEE35F7BA Q47552785-08D27757-09CE-4385-8822-08371CBD54BD Q49458822-8F432E82-9D8E-4DFE-8BF6-8117AAAB1B0B Q52593168-AF31274B-C73E-469C-B4F0-AEC5E2923C02 Q52594562-FBBCB6EE-2AB1-42BF-9D58-850EEA92313B Q52663098-072A1E49-1A7B-4583-B65E-7853691472B7 Q54979452-CAC1A67D-F0AB-4B0F-8D66-9BEB4D8B7376 Q54993920-E56760DA-327A-4778-8EC2-A00344FB037C Q55275094-1B57A1F2-5792-48C9-B058-A08057E9EB8D

P2860

Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.

http://www.wikidata.org/entity/Q34020747

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ultrastructural changes associ ...... d ocular hypertension in mice.

@ast

Ultrastructural changes associ ...... d ocular hypertension in mice.

@en

Ultrastructural changes associ ...... d ocular hypertension in mice.

@nl

type

label

Ultrastructural changes associ ...... d ocular hypertension in mice.

@ast

Ultrastructural changes associ ...... d ocular hypertension in mice.

@en

Ultrastructural changes associ ...... d ocular hypertension in mice.

@nl

prefLabel

Ultrastructural changes associ ...... d ocular hypertension in mice.

@ast

Ultrastructural changes associ ...... d ocular hypertension in mice.

@en

Ultrastructural changes associ ...... d ocular hypertension in mice.

@nl

P1433

Q34020747-6BB96BFD-7B65-4CF5-8099-C8C960A7971A

P1476

Q34020747-6218CB70-5727-4CD1-9686-A45985242DB9

P2093

Q34020747-174F47C7-A010-4E05-B1CA-0E47F813DB63

Q34020747-21A68EEB-01D6-4D84-A1A1-DA1AF94ED9F0

Q34020747-5BCE0961-FECC-47C8-9AD7-60F04637B657

Q34020747-89B00080-EAEC-4F80-A535-49DFCF8F65AE

Q34020747-9320CDB3-562A-4E8A-BAF4-338992E37CFB

Q34020747-9607D9F0-A39C-4E73-B923-1210FC92A50D

Q34020747-AB5E9D24-1C82-4678-8B3B-0211EB699B7E

Q34020747-D5809334-5DEC-408B-8A75-31F950ABA971

P2860

Q34020747-0391F76A-A241-445B-AE52-BF26B3F1E76B

Q34020747-0AB1EEC3-4FFB-489C-8292-EF6DEEEFBE62

Q34020747-105A520B-546F-4144-98CF-738A0B3B3CC1

Q34020747-11F5FD2A-AC19-4453-BEAC-78D119B5862E

Q34020747-14E11684-FCE5-4085-A996-866542CBA01F

Q34020747-23E9186E-F377-4284-857A-CC88EFFCEE80

Q34020747-2516FD74-640E-470C-9DB1-5550FB82CFAD

Q34020747-3BD5FF49-1FEB-48B6-9FDF-61637A74104A

Q34020747-4033E939-FE13-4897-A93A-FECA4015BC12

Q34020747-550515C8-DB2B-4C9D-AD3B-14CC3DABC046

P304

Q34020747-7633135B-B077-4E3F-8786-5DAB0911A9CC

P31

Q34020747-E7D2F87D-8EB3-402A-8089-D4BECB1ECFB5

P356

Q34020747-2F33FFAE-6A82-4D37-984F-6A512E795E1E

P407

Q34020747-0267970C-515A-4888-83AF-0A8BA3881941

P433

Q34020747-BBD1B46E-2249-4A6E-845E-A7DB6E0F4D4F

P478

Q34020747-539A9E32-2BB5-4072-9CE9-8825D077A659

P50

Q34020747-012E7DFB-F39C-4BA1-8DDA-BEDD2952B6A3

P577

Q34020747-E60F84AF-4B1E-443B-BCB8-E4F764C38E9F

P5875

Q34020747-8A00A308-5ACB-422A-AF3A-15F8D9B95779

P698

Q34020747-8A3ED126-AF8D-415B-BDEA-01BA98C27024

P921

Q34020747-19193D17-74D0-4781-9C11-C00DC8312249

P932

Q34020747-FCFFF90B-8BAB-4845-A8EB-EC94F70C33E9

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice

@en

P2093

Alexandra Boussommier-Calleja

http://www.w3.org/2001/XMLSchema#string

C Ross Ethier

http://www.w3.org/2001/XMLSchema#string

David F Woodward

http://www.w3.org/2001/XMLSchema#string

Elke Lütjen-Drecoll

http://www.w3.org/2001/XMLSchema#string

Jacques Bertrand

http://www.w3.org/2001/XMLSchema#string

Martin Schicht

http://www.w3.org/2001/XMLSchema#string

Ozan-Yüksel Tektas

http://www.w3.org/2001/XMLSchema#string

W Daniel Stamer

http://www.w3.org/2001/XMLSchema#string

P2860

Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues

Intraocular pressure in genetically distinct mice: an update and strain survey

Pharmacological validation of a feline model of steroid-induced ocular hypertension

Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: potential vulnerability to oxidative stress

Tissue plasminogen activator in trabecular meshwork attenuates steroid induced outflow resistance in mice.

Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.

Ocular changes in rabbits with corticosteroid-induced ocular hypertension.

The structure of the trabecular meshwork, its connections to the ciliary muscle, and the effect of pilocarpine on outflow facility in mice.

Pilocarpine-induced dilation of Schlemm's canal and prevention of lumen collapse at elevated intraocular pressures in living mice visualized by OCT.

Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus

P304

4922-4933

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.14-14429

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Darryl R. Overby

P577

2014-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263971726

http://www.w3.org/2001/XMLSchema#string

P698

25028360

http://www.w3.org/2001/XMLSchema#string

P921

P932

4126794

http://www.w3.org/2001/XMLSchema#string